Prodyut Biotech India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 06-07-2024
- Paid Up Capital ₹ 5.00 M
as on 06-07-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 180.29%
(FY 2022)
- Profit -32.00%
(FY 2022)
- Ebitda -34.21%
(FY 2022)
- Net Worth -990.82%
(FY 2022)
- Total Assets 17.32%
(FY 2022)
About Prodyut Biotech India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ramprasad Nagare and Sunil Krishna serve as directors at the Company.
- CIN/LLPIN
U33300MH2018PTC313807
- Company No.
313807
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prodyut Biotech India Private Limited offer?
Prodyut Biotech India Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Cattle Feed Additives, Broiler Feed, Animal Medicines & Health Care, Veterinary Medicines, Animal Feed Supplement.
Who are the key members and board of directors at Prodyut Biotech India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramprasad Nagare  | Director | 18-Feb-2022 | Current |
| Sunil Krishna | Director | 10-Sep-2018 | Current |
Financial Performance of Prodyut Biotech India.
Prodyut Biotech India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 180.29% increase. The company also saw a substantial fall in profitability, with a 32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 990.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prodyut Biotech India?
In 2022, Prodyut Biotech India had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prodyut Biotech India?
Unlock and access historical data on people associated with Prodyut Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prodyut Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prodyut Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
